Purchase Order HHSD2002017M93163P
Award Date 3/9/17
Potential Completion Date 7/14/17
Potential Value $198K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98104, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award by the Centers for Disease Control and Prevention (CDC) is for the procurement of ELISA detection kits from Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, valued at $85,485.00, is a firm fixed-price purchase order with an ultimate completion date of April 30, 2020. Inbios is a critical partner to the government, particularly during the COVID-19 pandemic, having secured numerous contracts with...
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Inbios International, Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The $61,575 contract is for the provision of Inbios' DETECT IgM Capture ELISA Kit and accessories, which are used for infectious disease diagnostics. The award does not have a set-aside designation. Inbios has received multiple previous federal contract and grant awards from the...
- This $806,303.37 cost-plus-fixed-fee delivery order contract was awarded by the Department of the Army Medical Command to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for other direct costs and does not have a set-aside designation. Inbios International specializes in the design, development, and manufacture of immunodiagnostic devices, and has received over $85 million in prime contract awards from agencies like...
- The U.S. Department of Health and Human Services, specifically the Office of the Assistant Secretary for Preparedness and Response, awarded a $20,736,000 firm-fixed-price definitive contract to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for the delivery of over-the-counter COVID-19 tests. The performance period is from September 20, 2023, to March 19, 2025. This contract has no set-aside designation, indicating...
- This federal contract award to Inbios International Inc., a minority-owned business based in Seattle, Washington, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The $749,998 firm fixed-price contract supports research and development (R&D) of an antibody diagnostic for COVID-19. The contract was issued under a Broad Agency Announcement (BAA) solicitation from ASPR's Division of...
- The Department of State Bureau of East Asian and Pacific Affairs awarded a firm fixed-price purchase order to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington, for $143,218.00. The contract is for the supply of CDC 7553.0/ELISA detection kits, which are immunodiagnostic devices used for infectious disease testing. Inbios has a history of federal contract awards and grants related to the development and manufacture of diagnostic tests,...
- This is a $12,670,301.06 firm fixed-price definitive contract awarded by the U.S. Department of Health and Human Services (DHHS) Biomedical Advanced Research and Development Authority (BARDA) to Inbios International, Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for the production capacity expansion of COVID-19 diagnostic tests and was awarded under Contracting Opportunity FA7013-20-S-0002, which did not have a set-aside designation....
- The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a cost-plus-fixed-fee definitive contract worth $7,735,010.61 to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for the development of point-of-care and laboratory-based immunoassays for the presumptive diagnosis of Zika virus infection. This contract is not set aside. Inbios is a key partner to...
- This federal contract award, valued at $5,508,014.60, was issued by the Medical Command (MEDCOM) to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract is for Information and Communications Technology (ICT) Development on a Cost-Plus-Fixed-Fee (CPFF) basis, with a completion date of July 20, 2019. Inbios, a Subchapter S Corporation, is a manufacturer of immunodiagnostic devices for infectious diseases. This contract award...
- This is a federal contract award to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, awarded by the Medical Command (MEDCOM) agency of the U.S. Department of Defense, is for ICT (Information and Communications Technology) development on a Cost-Plus-Fixed-Fee (CPFF) basis. The contract has a ceiling value of $1,724,742.02 and an ultimate completion date of September 18, 2019. The contract is not set-aside and was awarded...